spierafname door veroudering (sarcopenie) sarcopenia
Conditions
Interventions
Part A is a 12 week placebo controlled trial with 7.5 g additional leucine or
placebo supplementation daily (2.5 g/meal).
Part B is a 12 week resistance training program (3 times/week) combined with
Sponsors
Universiteit Maastricht
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Healthy male elderly, between 65 and 85 years old.
Exclusion criteria
Exclusion criteria: Impaired renal or liver function, obesity (BMI > 35), cardiovascular disease, diabetes (type I and II), hypertension, reduced physical performance, metal implants, COPD, Parkinson disease, rheumatoid arthritis, musculoskeletal/orthopedic disorders, regular aspirin use.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body composition, muscle caracteristics and muscle function will be compaired before and after interventions. | — |
Secondary
| Measure | Time frame |
|---|---|
| Plasma glucose responses will be compaired before and after interventions. | — |
Countries
Netherlands
Outcome results
None listed